Response to docosahexaenoic acid treatment in genetically matched malignant and nontransformed lung epithelial cells by Spencer, Kristen L.
Warning Concerning Copyright Restrictions 
 
The Copyright Law of the United States (Title 17, United States Code) governs the 
making of photocopies or other reproductions of copyrighted materials. 
 
Under certain conditions specified in the law, libraries and archives are authorized 
to furnish a photocopy or other reproduction. One of these specified conditions is 
that the photocopy or reproduction is not to be used for any purpose other than 
private study, scholarship, or research. If electronic transmission of reserve 
material is used for purposes in excess of what constitutes "fair use," that user may 
be liable for copyright infringement. 
 
 









Response to docosahexaenoic acid treatment in genetically matched malignant and 















A thesis submitted in partial fulfillment of the  
requirements for the degree of 













Kristen L. Spencer 








DHA is an omega-3 polyunsaturated fatty acid established to have anti-cancer effects in a 
variety of models of cancer.  The consequences of DHA supplementation on malignant 
cells has been widely studied, though little has been done on nontransformed cells. In the 
current study, an evaluation of DHA’s effect on two genetically matched pairs of 
malignant and nontransformed lung epithelial cell lines is proposed.  Current data 
suggests the two pairs of cell lines show significant differences in how well they respond 
to DHA treatment.  Cell signaling analysis showed a differential response between the 
neoplastic and nonneoplastic cell lines. Preliminary data showed the nontransformed and 
transformed cell lines to have a decrease in proliferation when treated with high doses of 
DHA.  In addition, lipid peroxidation as an indicator of oxidative stress was confirmed 
upon treatment with docosahexaenoic acid.  Further identifying the mechanisms of action 
is critical to understanding how response to DHA can be enhanced in tumors, while 
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 Epidemiological studies from the 1970’s initially spurred interest in diets rich in 
omega-3 polyunsaturated fatty acids (PUFAs), because populations consuming high 
amounts of these PUFAs demonstrated lower incidence of both cancer and cardiovascular 
disease [1].  Since then, a variety of research has been done on omega-3 PUFAs, most 
notably docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), to determine 
how they exert their anti-cancer effects. These outcomes have been attributed to a variety 
of mechanisms, including alterations in signal transduction, eicosanoid synthesis, 
membrane composition, and increases in reactive oxygen species [2].  DHA is 
particularly interesting, as it is the longest and most unsaturated fatty acid found normally 
in biological membranes having 22 carbons with 6 double bonds [3].  
 While a large amount of research has been done into how DHA affects malignant 
tumor models, very little work has been done on DHA’s impact on normal tissues.  
Interestingly, DHA has been implicated in protecting normal cells from traditional anti-
cancer treatments clinically, including radiation therapy and certain drugs [4].  
Understanding how DHA may be exerting these very different roles in tumors and 
normal tissue could provide valuable insight into how DHA might be effectively used as 
a combination therapeutic to enhance clinical outcomes with traditional treatments.  
 In the current study, we will use two pairs of genetically matched malignant and 
nontransformed lung epithelial cells E10/E9 and C10/A5 (with E9 and A5 being the 
malignant cell lines) to evaluate how DHA treatment influences their growth and 
signaling [5].  In order to develop these cell lines, researchers previously explanted lungs 
from a BALB/c mouse into culture, cloned, passaged them, and confirmed them to be 
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non-tumorigenic cells [6].  Upon treatment with dexamethasone, an immunosuppressant, 
they saw inhibited growth in most colonies but resistance in some.  The resistant colonies 
were then isolated, cloned and characterized.  Interestingly, upon subcutaneous injection 
to BALB/c mice these resistant clones produced tumors as determined by the cellular 
invasion of adjacent adipose and muscle tissue [6].  As genetic derivatives, minimal 
differences are present between the sibling pairs.  The transformed cells have a mutated 
k-Ras allele which provides for an increase in mRNA expression.  The Ras pathway is 
important in the transmission of growth-promoting signals from cell surface receptors, 
eventually travelling to the nucleus where these signals affect the production and 
regulation of other influential proteins [7].  Mutated p53 is also a hallmark of different 
cancers and is mutated in the E9, and A5 transformed lines affecting proliferative and 
apoptotic events [8].  Overall, these neoplastic and nonneoplastic transformants represent 
sibling pairs, and their genetic similarity provides for germane conclusions about the anti-
cancer affects exhibited by treatment with polyunsaturated fatty acids. 
 Numerous investigations have identified several mechanisms of action that DHA 
may be using to accomplish this affect including alterations in cell signaling, differential 
eicosanoid production, oxidative stress mechanism, and alterations in membrane fluidity.  
The potential methods of DHA’s anti-cancer trends have been identified in malignant 
human models, but more research must be completed before it can be definitively 
proclaimed [9].  This work will comprehensively analyze the previously identified trends 
using the genetically matched derivatives in order to confirm or deny the role that fatty 





Cell Lines and Reagents- E9 and E10 transformed and nontransformed murine lung 
epithelial cells were obtained from Dr. A. Malkinson.  Fatty acid methyl esters (Sigma, 
St. Louis, MO) were dissolved in ethanol (EtOH), flushed with nitrogen gas, protected 
from light and stored at -20°C for no more than 60 days. 
 
Cell Culture- E9 and E10 cells were maintained in CRML-1066 (Mediatech, Manassas, 
VA) and the A5 and C10 cells were maintained in DMEM 1x  (Mediatech, Manassas, 
VA).  Both medias were supplemented with 10% FBS (Atlanta Biological, Atlanta, GA), 
1% L-glutamine, and a mix of glucose, HEPES, and sodium pyruvate.  Cells were grown 
in single layer suspension at 37°C in a humidified environment with 5% CO2.   
 
Cell Viability Assays- Cell proliferation kit II (XTT) was performed on E9 and E10 cells 
after 48h treatment of DHA or LA at varying concentrations according to manufacturer 
protocol (Roche, Indianapolis, IN).  24 hours after plating, cultures were supplemented 
with either 150 uM, 100 uM, 75 uM, 50 uM, 25uM or 10 uM FAME of docosahexaenoic 
acid (DHA)  and linoleic acid (LA), or an equal volume of ethanol (EtOH) was added. 
The production of formazon dye was measured spectrophotometrically at 450nm 
referencing absorbance at 650nm and directly correlated with viable cells.  Manual cell 
counting was also performed following 75uM treatment as described above.  The single 
cell suspensions were washed twice with sterile phosphate buffered saline (PBS) and 
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trypsinized.  An equal volume of cells and trypan blue were mixed and counted using 
Hemacytometer counting method with percent differences relative to EtOH control. 
 
Lipid Peroxidation Assay- Fatty acid treatment was conducted as previously described at 
75uM and 100uM concentrations to be analyzed for lipid peroxidation.  Vitamin E was 
also incorporated at 50 uM concentration.  Dimethylsulfoxide was added in equal volume 
to groups not receiving Vitamin E.  Cell counts were obtained using Hemacytometer 
(Hausser Scientific) counting method described above and normalized to constant cell 
concentration.  GTP lysis buffer containing 20uL/ml PMSF, 20uL/ml Na3VO4, 10uL/ml 
Aprotinin, 10uL/ml NaF, and 10uL/ml protease cocktail was used in addition to manual 
displacement of cells through 26.5 gauge needle (Becton Dickinson & Co).  Equal 
volumes of lysate and 0.67% Thiobarbituric Acid in 20% Trichloracetic Acid were 
heated at 100°C for 20 minutes and placed on ice for 10 minutes. The samples were 
microcentrifuged for 5 minutes at 4°C.  The supernatant was removed and measured 
spectrophotometrically at 538nm for malondialdehyde equivalents. 
 
Protein Analysis- Cells cultured for Western blot analysis were scraped using GTP lysis 
buffer as described above.  Cell lysates were mixed with 1x Laemmli sample buffer and 
loaded at the protein concentrations indicated in the figure legends on Tris-Glycine gels 
(Invitrogen): 6% gels for growth factor receptor; 10% gels for β-actin and 
electrophoresed at 100V.  After transfer to nitrocellulose or PVDF (BioRad Laboratories) 
membranes, the blots were blocked in 5% dried milk for 2h at room temperature and 
probed overnight with antibodies at 1:1000 or 1:2000 dilution for growth factors and 
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HIF-1α respectively.  The appropriate secondary antibody was applied and an ECL kit 
(Amersham) was used for the detection of the bound antibody.  For reprobing with 
another antibody, blots were stripped in buffer containing 100 mM β-mercaptoethanol, 
2% sodium dodecyl sulfate (SDS), and 62.5 mM Tris for 30 minutes at 50°C and washed 
3 x 10 minutes with Tris buffered saline with 0.05% Tween-20. 
 
Fatty Acid Analysis- C10 and A5 cells were supplemented with docosahexaenoic acid, 
linoleic acid, or ethanol control at 100 uM for 48h and treated with 150ul freshly 
completed GTP-lysis buffer as previously described along with 0.02% butylated 
hydroxytoulene (BHT).  Cell homogenate was fatty acid extracted after addition of a 19:0 
standard.  Aliquots of organic solvents methanol (500ul) and methanolic hydrochloric 
acid (1,500ul) were applied to the samples and followed by a nitrogen flush. The samples 
incubated for 2h at 95°C and cooled to room temperature while drying with nitrogen. 
0.88% sodium chloride and hexane were added to the samples.  Nitrogen flushed the test 
tube and the samples were centrifuged at 1,000 x g for 5 min..  The hexane layer was 
removed to a clean test tube and another hexane layer was added, centrifuged as 
described and removed.  The pooled hexane fractions were stored at -20°C until further 
use. An Agilent Technologies 6890N Chromatograph, containing an SP2340 capillary 
column (Supelco, St. Louis, MO), was used.  A temperature program of a total time of 20 
min. with a starting temperature of 120°C was formulated.  The injector was set at 245°C 
and the flame ionization detector at 250°C.  The program was modified so that Rate 1 
was set at 5°C/min to 160°C and Rate 2 was set at 10°C/min to 240°C and held at 240°C 




 Two methods were used to determine DHA’s effect on cellular proliferation: 
Trypan blue staining for viable cells and XTT Assay for metabolically active cells.  
Interestingly, some variance was observed between the two experiment types while 
determining proliferation.  A measurable decrease in cellular proliferation was observed 
in the nontransformed and transformed pair E10/E9 after treatment with docosahexaenoic 
acid (DHA 22:6) at high concentrations using both methods (Fig. 1A, 2C).  This effect 
was observed at varying PUFA concentrations in both cell lines with the transformed 
component exhibiting an IC50 at 100 uM DHA supplementation.  The nontransformed 
cell line, E10, shows a higher decrease in proliferation at the same concentration of fatty 
acid.  The C10/A5 nontransformed and transformed pair also showed a response to PUFA 
treatment.  Supplementation with linoleic acid (LA 18:2) and DHA at 100 uM were 
applied as well as an equal volume of ethanol control.  The nontransformed-C10 cell line 
showed a 53.05% decrease in proliferation versus ethanol control when treated with 
DHA.  Treatment with linoleic acid showed an increase of 122.18% in proliferation in the 
A5 neoplastic line.  The A5 cell line also showed an increase in proliferation upon DHA 
treatment using the XTT method (Fig. 1B).  This data contradicts the measured cell 
viability through Trypan blue staining with manual cell counts.  The secondary method 
showed a decrease in the number of viable A5 cells when treated with DHA (Fig. 2D).  
Despite contradictions in preliminary data, this information may provide insight to the 
validity of the murine lung epithelial response to fatty acid treatment and its correlation 
with previously published data on immortalized human carcinoma cell lines. 
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 Lipid peroxidation, an indicator of oxidative stress, was confirmed upon treatment with 
DHA in the genetically matched transformants (Fig. 2A, B).  The nontransformed E10 
cell line exhibited the highest amount of lipid peroxidation at 212.38% malondialdehyde 
(MDA) formed relative to EtOH control (Fig. 2A).  Increases in MDA were still observed 
in the other cell lines in lesser amounts after treatment with DHA at 100 uM (Fig. 2A, B).  
Vitamin E, or α-tocopherol, an essential nutrient, was used in this experiment for its 
function in counteracting lipid peroxidation by removing lipid radicals thus protecting the 
lipid membranes from damaging oxidation.  It was shown to decrease the lipid 
peroxidation when combination treatment of DHA and Vitamin E was used (Fig. 2A, B).  
Manual cell counts were completed to verify previously reported cellular proliferation 
data.  Hemacytometer counting method after Trypan blue staining was used.  In the 
transformed and nontransformed E10/E9 sibling pair, a decrease in viable cells was 
observed in a dose dependent correlation based on increasing concentration of DHA 
treatment (Fig. 2C).  The experiment was repeated in the C10/A5 cell lines, and the dose 
dependent decrease in viable cells was confirmed (Fig. 2D).  In addition, upon treatment 
with linoleic acid an increase in viable cells relative to ethanol control was observed in 
both C10/A5 transformants (Fig. 2D).  It has been observed when cellular proliferation is 
decreased by DHA treatment lipid peroxidation is increased; this may provide insight to 
one aspect of the anti-cancer mechanism of action that DHA takes. 
 To confirm fatty acid incorporation into the membrane, a hexane fatty acid 
extraction was completed as well as analysis with gas chromatography.  The presence of 
DHA was confirmed to incorporate at high levels in the cell upon 100 uM treatment in 
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the A5 and C10 cell lines (Fig. 3).  In addition, linoleic acid was confirmed to incorporate 
at higher levels into the membrane (Fig. 3).  Data must be repeated before the fatty acid 
composition trends can be definitively described.  The presence of arachidonic acid was 
approximately three fold higher in the nontransformed C10 cell line compared to the 
transformed A5 cell line when treated with docosahexaenoic acid (Fig. 3).  As 
arachidonic acid is a key inflammatory intermediate, it may be inferred that the 
nontransformed cell line is altering eicosanoid production in response to the fatty acid 
supplementation. 
 Epidermal growth factor receptor (EGFR) is a key membrane bound protein 
known previously to be affected by DHA supplementation through alterations of the 
membrane microdomain excluding EGFR from lipid rafts [10].  In a variety of 
immortalized human lines such as A549 lung adenocarcinoma, WiDr colon carcinoma, 
and MDA-MB-231 breast carcinoma, there has been demonstrated promise for 
combination therapy between EGFR inhibitors and DHA.  Its downstream signals can 
alter cellular proliferation, apoptosis, and necrosis along with translocation of molecules 
to the nucleus affecting DNA replication specifically through the Ras/MAPK signaling 
cascade.  EGFR is overexpressed in a variety of cancers and is a current target in 
numerous clinical therapeutics.  We have used Western blot techniques to probe for 
activation of EGFR as shown by phosphorylation at the Y1068 residue.  In the C10/A5 
sibling pair, there is a marked decrease in signal upon treatment with DHA when 
compared to EtOH or linoleic acid (Fig. 4).  In addition, there is an absence of expression 
of total EGFR in the DHA treated cells.  In the nontransformed C10 cell line, EGFR 
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appears to have an increase in expression when treated with 100 uM linoleic acid (Fig. 4).  
Hypoxia inducible factor (HIF-1α) is a protein found in mammalian cells under reduced 
oxygen environments which plays an essential role in maintaining cellular and systemic 
homeostatic responses.  Intratumoral hypoxia and genetic alterations can lead to HIF-1α 
overexpression, which has been correlated with increased patient mortality in a variety of 
cancers [11].  Treatment with DHA resulted in a downregulation of HIF-1α expression 
(Fig. 4).  While these trends may provide insight to the alterations in cellular signaling, 




  This study demonstrates the differential effect that DHA supplementation has in 
vitro on two genetically matched pairs of murine lung epithelial cells.  DHA 
supplementation has not previously been investigated in these cell lines.  The conclusions 
drawn provide to be specifically germane as there are minimal genetic differences 
between the sibling pairs apart from p53 and k-Ras mutations influencing metastasis.  
The data presented here establishes treatment with docosahexaenoic acid to result in 
decreases in proliferation in the nontransformed and transformed E10/E9 cell lines as 
well as the transformed C10 cell line (Fig. 1).  Furthermore, lipid peroxidation was 
confirmed to correlate with a decrease in viable cells upon treatment with DHA (Fig. 2). 
This inhibition can be attributed to the increase of oxidative stress observed.  As DHA is 
the longest, unsaturated fatty acid normally found in biological membranes, its high 
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number of conjugations presents itself as a target of peroxidation.  Vitamin E 
demonstrated its known antioxidant properties by counteracting the oxidative stress 
presented in DHA treatment and decreasing lipid peroxidation (Fig. 2).  Interestingly, 
lipid peroxidation in the matched E10/E9 pair provided to be one of the few differential 
responses elicited between the sibling pairs.  The E10 cell line produced increased 
amounts of malondialdehyde and seemingly had less antioxidant sensitivity.  It will be of 
the best interest to complete the Oxygen Radical Absorbance Capacity (ORAC) Assay to 
directly analyze at the antioxidant effects present in relation to DHA treatment. 
Furthermore, cell signaling analysis showed a differential response upon 
supplementation with DHA.  EGFR Y1068, which is almost universally increased in 
transformed human cell lines upon DHA supplementation, is decreased in the murine 
normal and neoplastic cells (Fig. 4).  Phosphorylation at this residue results in activation 
of the protein.  EGFR is a crucial membrane bound protein that affects the Ras/MAPK 
pathway as well as PI3K affecting cellular proliferation and apopotic events.  Decreases 
in HIF-1α were also observed upon supplementation with DHA (Fig. 4).  Traditionally in 
other cancer models, HIF-1α is consistently overexpressed.  The downregulation of this 
crucial protein provides insight into the alterations in cell signalling due to treatment with 
DHA.  More probing must be completed in order to identify the interactions with other 
proteins that affect cell death or survival.  In addition, fatty acid analysis showed to DHA 
incorporate into the membrane, which is where it initiates its anticancer effects (Fig.4). 
 The mechanisms of action of DHA are many and much work is still to be done to 
definitively elucidate which facets of tumorigenesis are altered.  DHA has been 
previously shown to elicit a protective effect on normal tissue when used in clinical 
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anticancer therapies [11].  Nutritional supplementation as a non-invasive addition to 
traditional anti-cancer therapies may provide an amplified decrease in tumorigenesis [12].  
Further investigations must be conducted to determine if murine carcinomas are 
exhibiting different biochemical properties than human lines.  Identifying differences in 
how these matched cell lines respond to DHA supplementation to understand how DHA 
can enhance response of tumors, while improving the health of normal tissues in the 
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